Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02165059 · ClinicalTrials.gov registry record
GI Neuromuscular Pathology Prospective Registry
A clinical trial of Gastroparesis, sponsored by Indiana University.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT02165059: Recruiting study of Gastroparesis, sponsored by Indiana University.
NCT02165059 is a study of Gastroparesis that is actively recruiting participants, run by Indiana University. The registered enrollment target is 300 participants, roughly in line with the 295-participant average among 44 other Gastroparesis trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02165059, a study of Gastroparesis, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
In this research study, biopsy samples will be collected to provide more insight into the underlying cause of the motility disorders, help direct further investigation into the cause of the underlying condition, provide future prognosis and predict response to gastric electrical stimulation (GES).
Primary Outcome
To determine if ICC abnormalities of the stomach and proximal jejunum can be used as a biologic marker in predicting clinical outcome in patients undergoing surgical implantation of gastric electrical stimulation (GES) for severe gastroparesis.
Conditions Studied
Interventions
- PROCEDURE Surgical Full Thickness Biopsy
Study Locations (1)
Indiana
- Indiana University Hosptial - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2013-12 |
| Est. Completion | 2025-12 |
What NCT02165059 shows while recruiting
NCT02165059 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 295-participant average among 44 other Gastroparesis trials with a reported enrollment target.
The record links to 1 condition, with Gastroparesis appearing as the primary indexed condition, and to 1 intervention - of which Surgical Full Thickness Biopsy is the first listed.
NCT02165059 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT02165059 about?
NCT02165059 is a clinical study titled "GI Neuromuscular Pathology Prospective Registry". In this research study, biopsy samples will be collected to provide more insight into the underlying cause of the motility disorders, help direct further investigation into the cause of the underlying condition, provide future prognosis and predict response to gastric electrical stimulation (GES).
What is the current status of trial NCT02165059?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2013-12. Estimated completion is 2025-12.
What conditions does trial NCT02165059 study?
This clinical trial studies the following conditions: Gastroparesis.
What interventions are being tested in trial NCT02165059?
The interventions under investigation include: Surgical Full Thickness Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT02165059?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02165059 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroparesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02165059's enrollment target sits among peer trials
300 7th of 44 higher than 37 of 44 other Gastroparesis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastroparesis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gastroparesis Registry 4
RECRUITING
-
The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM
RECRUITING · NA
-
Study of Gastric Motility in Eosinophilic Gastritis
RECRUITING
-
Indiana University Gastrointestinal Motility Diagnosis Registry
RECRUITING
-
Compassionate Use of Domperidone for Refractory Gastroparesis
RECRUITING · NA
-
Central and Peripheral Effects of Cognitive Behavioral Therapy on Brain-Gut Axis Signaling in Gastroparetic Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia